Skip to main content
. 2021 Nov 11;8:766996. doi: 10.3389/fcvm.2021.766996

Table 3.

One-year mortality in infective endocarditis patients.

Total
(n = 3,085)
IE + cancer
(n = 359)
IE – cancer
(n = 2,726)
P -value
Death 233/2,108 (11.1%) 43/239 (18.0%) 190/1,869 (10.2%) <0.001
Cause of death
Cardiovascular 57/233 (24.5%) 6/43 (14.0%) 51/190 (26.8%) 0.240
Non-cardiovascular 65/233 (27.9%) 16/43 (37.2%) 49/190 (25.8%)
Cardiovascular + Non-cardiovascular 49/233 (21.0%) 9/43 (20.9%) 40/190 (21.1%)
Unknown 62/233 (26.6%) 12/43 (27.9%) 50/190 (26.3%)
If cardiovascular:
Heart failure 74/106 (69.8%) 9/15 (60.0%) 65/91 (71.4%)
Arrhythmia 9/106 (8.5%) 3/15 (20.0%) 6/91 (6.6%)
Cardiac perforation/tamponade 1/106 (0.9%) 0/15 (0.0%) 1/91 (1.1%)
Acute MI 7/106 (6.6%) 1/15 (6.7%) 6/91 (6.6%)
Cerebral embolism 7/106 (6.6%) 2/15 (13.3%) 5/91 (5.5%)
Pulmonary embolism 5/106 (4.7%) 1/15 (6.7%) 4/91 (4.4%)
Peripheral embolism 1/106 (0.9%) 0/15 (0.0%) 1/91 (1.1%)
Other cardiovascular 27/106 (25.5%) 1/15 (6.7%) 26/91 (28.6%)
If non-cardiovascular:
Neoplasia 22/114 (19.3%) 15/25 (60.0%) 7/89 (7.9%)
Sepsis 60/114 (52.6%) 7/25 (28.0%) 53/89 (59.6%)
Other 41/114 (36.0%) 6/25 (24.0%) 35/89 (39.3%)

MI, Myocardial infarction.